Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002070346 | SCV002454381 | likely benign | X-linked Emery-Dreifuss muscular dystrophy | 2023-06-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004616751 | SCV005114679 | likely benign | Cardiovascular phenotype | 2024-04-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Diagnostic Laboratory, |
RCV001528539 | SCV001740417 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001528539 | SCV001951202 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001528539 | SCV001970783 | likely benign | not provided | no assertion criteria provided | clinical testing |